tiprankstipranks
Trending News
More News >
Humacyte (HUMA)
NASDAQ:HUMA
US Market

Compare Humacyte (HUMA) vs. Competitors

Compare
1,540 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Humacyte
$1.10
$212.30M
-4.65
-75.22%
3 Buy
0 Hold
0 Sell
Strong Buy
Cartesian Therapeutics
$7.42
$191.39M
-60.80%
6 Buy
2 Hold
0 Sell
Strong Buy
Allogene Therapeutics
$1.61
$361.82M
-1.66
-11.41%
10 Buy
0 Hold
0 Sell
Strong Buy
Foghorn Therapeutics
$6.02
$367.89M
-5.07
43.33%
9 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$8.36
$498.17M
-2.25
143.73%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HUMA
Humacyte
1.11
-3.45
-75.66%
RNAC
Cartesian Therapeutics
7.42
-12.43
-62.62%
ALLO
Allogene Therapeutics
1.63
-0.21
-11.41%
IMAB
FHTX
Foghorn Therapeutics
6.02
1.61
36.51%
KYTX
Kyverna Therapeutics, Inc.
8.36
5.02
150.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts